Clinical Trial Update: Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study [Phase 2]

View source ↗

Summary

This update covers a multicenter Phase II trial of gemcitabine plus cetuximab in patients with advanced or metastatic biliary tract cancer. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Time to Progression | Phase 2 | Status: COMPLETED